C-peptide is released by the pancreas in equal amounts with insulin, but it lasts longer in the blood and isn't affected by insulin injections. That makes it a steadier read on how much insulin your pancreas is actually producing.
High fasting C-peptide points to the pancreas working overtime to control blood sugar, an early sign of insulin resistance, often before glucose or A1c rise. Low C-peptide suggests the pancreas is producing too little insulin. Read together with fasting insulin, glucose and HOMA-IR.
Optimal C-Peptide: 1-2 ng/mL.
Typically re-tested every 12 weeks.
Compare your result with the range printed on your lab report. FitScript's optimal range is 1 to 2 ng/mL.
C-peptide is the connecting fragment left behind when the pancreas splits its insulin precursor into usable insulin, and it enters the bloodstream in a one to one ratio with that insulin.
Beta cells in the pancreas first build a single precursor molecule called proinsulin. Inside the secretory granule, enzymes cut that molecule into two pieces, the insulin molecule itself and the connecting peptide that gives C-peptide its name. Both are released together, which is why measuring one tells you a great deal about the other 1.
The reason labs regard C-peptide as a useful stand-in for insulin output is what happens after release. Insulin made by the pancreas travels first to the liver, which removes a large and variable share of it before it ever reaches the vein in your arm. C-peptide is not extracted by the liver in the same way. It is cleared mainly by the kidneys and circulates longer, so its concentration in peripheral blood is steadier and reflects total secretion more faithfully than a single insulin measurement does 2.
There is a second reason the marker earns its place on a panel. Manufactured insulin contains no C-peptide. In people already using insulin therapy, a measurable C-peptide result reflects what the pancreas itself is still making rather than what was injected, which is why research describes it as the standard way to assess remaining beta cell function 3.
It matters because it describes the supply side of blood sugar control, how hard your pancreas is working, which glucose and HbA1c cannot show on their own.
Two people can share an identical fasting glucose for opposite reasons. One may be producing plenty of insulin while tissues respond poorly, so the pancreas compensates by pushing out more. The other may be producing very little insulin, with glucose drifting up because there is not enough signal to move it into cells. Research suggests that measuring C-peptide with a simultaneous glucose helps separate those two pictures, and clinicians use it to clarify which form of diabetes a person has and how it should be managed 4.
Both patterns carry weight over years rather than weeks. At the other end of the scale, preserved secretion appears to be protective of day to day stability. Studies in younger populations indicate that residual beta cell function is associated with steadier glucose and a smoother course over time 6.
C-peptide has also been studied as more than a passive by-product. Research suggests the molecule may have biological activity of its own in tissues affected by diabetes complications, although that evidence is still developing and findings are not consistent across studies 5. For now, its established value is as a window onto how much insulin you make.
Compare your result with the range printed on your lab report. FitScript's optimal range is 1 to 2 ng/mL.
| Reading | Range (fasting) |
|---|---|
| Lab reference range | As printed on your lab report |
| FitScript optimal range | 1 to 2 ng/mL |
Reference ranges vary by lab, age and sex, and the reference interval printed on your own report is the one to compare your value against. FitScript's optimal range is an optimization target rather than a diagnostic cut-off, so a result outside it is a prompt for a conversation, not a verdict.
Two practical notes. First, some labs report in nmol/L rather than ng/mL, so check the units before comparing two reports. Second, assays for this marker are not fully harmonised across laboratories, and a call for standardisation of measurement has been published in the clinical literature 8. In practice that means serial results are most informative when they come from the same lab using the same method.
A result also means little in isolation. Because secretion responds to blood sugar, interpretation depends on the glucose measured from the same draw, and on whether the sample was fasting or taken after a meal or a stimulation test 1.
A high result means the pancreas is releasing a large amount of insulin, and on its own it does not identify why.
Many people with a raised value feel nothing unusual. Among those who do report symptoms, the common descriptions are heavy fatigue in the hour or two after a carbohydrate-rich meal, strong hunger or cravings between meals, difficulty losing weight around the middle, and sometimes darkened velvety patches of skin in folds such as the neck or armpits, a finding often associated with insulin resistance.
Common reasons a value sits high include:
A suboptimal result is worth discussing with a clinician alongside your glucose, HbA1c and lipids rather than acted on alone.
A low result means little insulin is being produced at the moment of the draw, which is informative only when you also know what the blood sugar was at that moment.
After a long fast, with normal glucose, low output is expected physiology. The combination that carries clinical weight is a low value with a raised glucose. People in that situation often report increased thirst, frequent urination, unexplained weight loss, fatigue and blurred vision, and that mix of symptoms is worth discussing with a clinician promptly rather than waiting for a routine appointment.
Reasons a value sits low include:
Over the longer term, the amount of residual function that remains is clinically meaningful. Repeat measurement is used to follow residual beta cell function over time 6. Research also supports its use in deciding whether insulin therapy is the appropriate approach for an individual, a decision that belongs to a licensed provider who has reviewed the whole picture 7.
More than your underlying biology. Testing conditions, kidney function, medicines and the assay itself all move the number, which is why one reading rarely settles a question.
Testing conditions. Fasting status is the single biggest variable, since secretion rises after eating. Some assessments deliberately use a stimulated sample, taken after a standardised mixed meal or a stimulating agent, because a stimulated value gives a better estimate of maximum capacity than a fasting one 1. Whichever approach is used, a glucose drawn at the same time is part of the interpretation.
Kidney function. Clearance is largely renal, so reduced kidney function raises measured levels independently of how much insulin the pancreas is making 2 10. Kidney markers are therefore part of reading the result.
The laboratory. Methods differ between labs and a formal call for standardisation of measurement has been made in the literature, so a change between two reports from different laboratories may partly reflect the assay rather than you 8. Where possible, repeat with the same lab.
Medicines. Agents that stimulate insulin release from beta cells raise the value, while injected insulin does not contribute to it at all, which is precisely what makes the marker useful in people using insulin. Prescription metabolic therapies, including GLP-1 based medicines, influence insulin secretion and glucose, and a licensed provider evaluates whether any of them is appropriate for a given person. This article gives no doses, schedules or administration guidance for any prescription therapy.
Habits and context. Recent carbohydrate intake, meaningful weight change, physical activity, poor sleep and acute illness or stress can all shift insulin demand and therefore secretion. These influences may act mainly through insulin sensitivity, which is why lifestyle context is worth recording alongside a result rather than treated as noise.
FitScript does not currently test this marker in a panel. Members have 150+ biomarkers tested per year, and this one is not among them at present.
If you already have a result from another lab or a clinician, you can upload your labs so that Atlas, FitScript's AI health advisor, can read it alongside your other metabolic markers rather than in isolation. Atlas uses what it sees to build your FitScript, the personalised output written from your own biology, and an out-of-range value is flagged as something to review with a clinician rather than acted on automatically. Where a prescription therapy enters the conversation, a licensed provider reviews the member and decides whether it is appropriate.
The practical value of uploading is context. A single insulin-related number means far more when it sits next to a fasting glucose, an HbA1c and a calculated measure of insulin resistance from the same period, because those together describe both the demand on the pancreas and its response.
The markers that make this one interpretable are the rest of the insulin and glucose picture. Fasting Insulin measures the hormone itself and is the closest companion, though it is affected by liver extraction in a way C-peptide is not. Fasting Glucose supplies the context without which any secretion result is ambiguous, and Hemoglobin A1C adds the longer average that a single morning draw cannot show. HOMA-IR and its updated form HOMA2-IR combine fasting glucose and insulin into an estimate of insulin resistance, which is often the question behind ordering any of these tests. Uric Acid is worth including too, since it is associated with insulin resistance and tends to move with the same metabolic pattern.
C-peptide is released one for one with insulin and survives longer in the blood, so it is the cleanest routine estimate of how much insulin your own pancreas is making, including in people already using insulin. High values point towards heavy output, commonly in the setting of insulin resistance or reduced kidney clearance. Low values point towards limited output, and a low value with a raised glucose deserves prompt clinical attention. Interpretation always depends on the glucose from the same draw, the lab that ran it and the medicines you take.
This article is educational and is not medical advice. Discuss your results, and any treatment decision that follows from them, with a clinician or licensed provider who knows your full history.
It measures the connecting peptide that the pancreas releases into the blood in equal amounts to insulin whenever it produces insulin. Because the liver removes much of the insulin before it reaches a peripheral vein while C-peptide circulates longer, the result gives a steadier estimate of how much insulin your own body is making.
Fasting status changes the result substantially, since secretion rises after eating, so follow the instruction given on your lab requisition. Some assessments deliberately use a sample taken after a standardised meal or a stimulating agent to estimate maximum capacity. Whichever is used, a glucose drawn from the same sample is part of the interpretation.
FitScript's optimal range is 1 to 2 ng/mL. Reference ranges vary by lab, age and sex, and some labs report in nmol/L, so compare your value against the interval printed on your own report.
Two reasons. Insulin is partly removed by the liver before it reaches the arm, which makes peripheral insulin a noisier estimate of secretion. And manufactured insulin contains no C-peptide, so in people already using prescribed insulin this marker still reflects what the pancreas itself is producing.
A high value is associated with insulin resistance, where tissues respond poorly and the pancreas compensates with greater output, but it is not a diagnosis. Reduced kidney clearance, a non-fasting sample and medicines that stimulate insulin release can also raise it. Review a high value with a clinician alongside glucose and HbA1c.
Look at the glucose from the same draw. A low value after a long fast with normal glucose can be ordinary physiology, while a low value with a raised glucose, particularly alongside thirst, frequent urination or unexplained weight loss, is worth discussing with a clinician promptly. Never ignore an out-of-range result.
Insulin demand can shift with carbohydrate intake, body composition, physical activity, sleep and acute illness, and secretion follows demand. Changes are gradual rather than immediate, and they are best tracked with repeat testing at the same laboratory alongside glucose and HbA1c rather than from a single reading.
Not at present. FitScript members have 150+ biomarkers tested per year, and this one is not currently part of a panel. Anyone who already holds a result from another lab can upload their labs so Atlas can read it alongside their other metabolic markers.